COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1567: Articles 15661-15670  | Next

Forecasting COVID-19 disease cases using the SARIMA-NNAR hybrid model
Demir, I., Kirisci, M.
10.1101/2021.04.26.21256108 — Posted: 2021-04-28
Reopening California: Seeking Robust, Non-Dominated COVID-19 Exit Strategies
Nascimento de Lima, P., Lempert, R., Vardavas, R., Baker, L., Ringel, J., Rutter, C. M., Ozik, J., Collier, N.
10.1101/2021.04.26.21256105 — Posted: 2021-04-28
Physician Perceptions of Surveillance: Wearables, Apps, and Bots for COVID-19
Linares, A. R., Bramstedt, K. A., Chilukuri, M. M., Doraiswamy, P. M.
10.1101/2021.04.26.21256102 — Posted: 2021-04-28
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana
Quashie, P. K., Mutungi, J. K., Dzabeng, F., Oduro-Mensah, D., Opurum, P. C., Tapela, K., Udoakang, A. J., WACCBIP COVID-19 Team, , Asante, I., Paemka, L., Kumi-Ansah, F., Quaye, O., Amoako, E., Armah, R., Kilba, C., Boateng, N. A., Ofori, M. F., Kyei, G. B., Bediako, Y., Ndam, N. T., Abugri, J., Ansah, P., Ampofo, W. K., Mutapi, F., Awandare, G. A.
10.1101/2021.04.25.21256067 — Posted: 2021-04-28
Deprivation and Exposure to Public Activities during the COVID-19 Pandemic in England and Wales
Beale, S., Braithwaite, I., Navaratnam, A. M., Hardelid, P., Rodger, A., Aryee, A., Byrne, T. E., Fong, W. L. E., Fragaszy, E., Geismar, C., Kovar, J., Nguyen, V., Patel, P., Shrotri, M., Aldridge, R. W., Hayward, A. C., Virus Watch Collaborative
10.1101/2021.04.26.21255732 — Posted: 2021-04-28
Evolving Phenotypes of non-hospitalized Patients that Indicate Long Covid
Estiri, H., Strasser, Z., Brat, G., Semenov, Y., Patel, C., Murphy, S.
10.1101/2021.04.25.21255923 — Posted: 2021-04-28
SARS-CoV-2 virus transfers to skin through contact with contaminated solids
Behzadinasab, S., Chin, A. W. H., Hosseini, M., Poon, L. L. M., Ducker, W. A.
10.1101/2021.04.24.21256044 — Posted: 2021-04-28
Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan
Sunohara, S., Asakura, T., Kimura, T., Ozawa, S., Oshima, S., Yamauchi, D., Tamakoshi, A.
10.1101/2021.04.18.21255682 — Posted: 2021-04-27
Estimating the false positive rate of highly automated SARS-CoV-2 nucleic acid amplification testing
Chandler, C. M., Bourassa, L., Mathias, P. C., Greninger, A. L.
10.1101/2021.04.25.21254890 — Posted: 2021-04-27
Rapid and simultaneous identification of three mutations by the NovaplexTM SARS-CoV-2 Variants I Assay kit
Kami, W., Kinjo, T., Arakaki, W., Oki, H., Motooka, D., Nakamura, S., Fujita, J.
10.1101/2021.04.27.21255987 — Posted: 2021-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).